Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    Asia Pacific Bioreactors Market Size By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By Product Type (Single-use, Reusable), By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), By End-user (R&D Organizations, Biopharmaceutical Manufacturers, Contract Manufacturing Organizations [CMOs]), Industry Analysis Report, Regional Outlook (China, Japan, India, South Korea, Australia, Singapore, Indonesia, Malaysia, Philippines, Thailand), Application Potential, Competitive Market Share & Forecast, 2020 - 2026
    Published Date: October 2020   |   Report ID: GR1234   |   Delivery: PDF  Request Free Sample

    Industry Trends

    Asia Pacific Bioreactors Market growth was valued at USD 764.3 million in 2019 and is expected to witness over 15.6% CAGR from 2020 to 2026.

    Bioreactors or fermentors are vessels wherein chemical processes are carried out using organisms or biochemically active substances. They are widely used in the areas of biopharmaceuticals, vaccines, and research and development of various novel entities.

    Asia Pacific Bioreactors Market

    Get more details on this report - Request Free Sample PDF

    Innovations in single-use bioreactors will offer momentous growth opportunities to Asia Pacific bioreactors market. Advances in bioreactors have presented standardization and automation in bioprocessing along with advantages related to time. These advancements include continuous manufacturing, remote monitoring of culture process, integration of analytical technology, and single-use systems. Additionally, single-use bioreactors are cost-effective that further increases their preference among customers.

    Asia Pacific Market, By Product Type

    Bioreactors market is segmented as single-use bioreactors and reusable bioreactors based on product type. Reusable bioreactors segment held over 75% revenue share in 2019. Reusable bioreactors assist in the production of drugs and vaccines at larger volume and scale. Since there are numerous pharmaceuticals and biologics manufacturers along with contract manufacturing organizations in countries such as China and India, the segment will foresee robust growth.

    Asia Pacific Market, By Cell

    Bioreactors market is segmented on the basis of cell as mammalian cells, bacterial cells, yeast cells and others. Mammalian cells segment held over USD 590 million revenue size in 2019. Mammalian cells have wide adoption as they have use in bioprocessing of viral vaccines, therapeutics and diagnostic proteins. They are also used for research purposes. Thus, increasing adoption of mammalian cells coupled with growing vaccines and biologics industry will in turn boost the segmental growth over the analysis period.

    Asia Pacific Market, By Molecule

    Based on molecule, bioreactors market is segmented as monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy and others. Stem cells segment is forecasted to proceed at more than 16.5% CAGR. Rising number of research activities to develop stem cell therapy for a wide range of applications including regenerative medicine and aesthetic medicine will increase the segment growth. In addition, increasing focus and investment by firms for R&D in this space will further influence segmental size expansion.

    Asia Pacific Market, By End-user

    On the basis of end-users, bioreactors market is segmented as R&D organizations, biopharmaceutical manufacturers, contract manufacturing organizations (CMOs). Adoption of bioreactors in contract manufacturing organizations will expand during the analysis period. Numerous companies based in the developed countries outsource manufacturing activities to Asian countries owing to cost advantage. Thus, with growing need for cost containment and hence, increasing number of CMOs in the region, the demand for bioreactors will increase in the forthcoming years.  

    Asia Pacific Market, By Country

    India bioreactors market held over 17% market share in 2019. Presence of major market players in the country will serve to be high impacting factor for market growth. Presence of market players positively impact product availability and supply. In addition, there are several biopharmaceutical companies and CMOs, that will further create demand for bioreactors in the nation in the forecast timeframe.

    Competitive Market Share

    Some of the major industry players involved in Asia Pacific bioreactors market include Sartorius Stedim Biotech, Cytiva, Merck, Thermo Fisher Scientific, and Eppendorf AG among others. Market players are undertaking various strategies such as collaborations, and product launch to strengthen their market position. For instance, in November 2019, Applikon Biotechnology introduced 3L single-use bioreactor for lab-scale production expanding its AppliFlex ST Family of single-use bioreactors. This product portfolio expansion has boosted firm’s revenue, thus strengthening company’s footprint in the market.

    Industry Background

    Bioreactors or fermentors were used for production of chemicals, specialized molecules, probiotics among several other substances. Stainless steel bioreactors were used widely for mass production of various end products. With high cost being associated with reusable bioreactors, single-use bioreactors were developed. These bioreactors offer effective and affordable option to reusable bioreactors. With growing research and development and budget constraints, these systems are being widely adopted. Thus, Asia Pacific market will witness rapid demand for advanced bioreactors with expanding pharma industry and entry of numerous lifesciences firms in the foreseeable future.

    Frequently Asked Question(FAQ) :

    Which is driving factor of Asia Pacific Bioreactors Market?
    Growing demand for therapeutically active vaccines along with increasing prevalence of lifestyle diseases such as diabetes and cancer will augment business growth.
    Which segment has maximum share revenue in 2018?
    Mammalian cell segment held maximum revenue shares accounting of USD 110.1 million in 2018.
    What accelerates this market in Japan?
    Increasing number of biopharmaceutical companies responsible for bringing new medicines to patients and their collaborations with academic institutions and venture capital firms will accelerate the Japan bioreactors market

    Get this research report on Asia Pacific Bioreactors Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]